GLORAMP PHARMA CONSULTING LIMITEDActive
Key figures
Like most small UK companies, GLORAMP PHARMA CONSULTING LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Total assets | 33,992 | 12,132 | 34,356 | 124,758 | 175,819 |
| Total liabilities | 31,603 | 11,445 | 20,752 | 53,591 | 52,032 |
| Net assets / total equity | 2,389 | 687 | 13,604 | 71,167 | 123,787 |
| Average number of employees | 1 | 1 | 1 | 2 | 3 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: GLORAMP PHARMA CONSULTING LIMITED
Company
GLORAMP PHARMA CONSULTING LIMITED is a private limited company registered with Companies House under company number 09129477. It was incorporated on 14 Jul 2014. Its status is active. The registered office is in Aylesbury (HP19). Its nature of business (SIC 2007) is technical testing and analysis (71200).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files micro-entity accounts. Net assets were £123,787, up 73.9% on the previous year. Total assets were £175,819 and total liabilities £52,032. The company had an average of 3 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 24 Apr 2027.